GXP Engaged is a leading provider of Good Clinical/Pharmacovigilance Practice (GCP/GVP) audit and related consulting services to the pharmaceutical and biotech sectors.
The investment will enable continued growth led by the CEO Ian Montague who is a skilled and experienced leader in the sector. GXP Engaged is well placed to capitalise on the global drug development pipeline and leverage its exceptional reputation for quality.
Following the deal we are continuing to support Ian as he builds a senior team to deliver the growth plan.
“I found the process to be very professionally conducted with an extremely clear briefing of the purpose, process and beneficial outcomes. The profiling and detailed report have helped establish a strong foundation for communication and collaborative working between me as a CEO and our PE partner.”
Ian Montague, CEO GXP Engaged